Abstract
Although the mechanisms underlying neurodegeneration in Parkinson's disease are not fully understood, considerable evidence suggests that genetic factors can influence susceptibility to the disease. In this article, we critically review this evidence and examine studies estimating patterns of inheritance. In a few families, Parkinson's disease is clearly inherited in a Mendelian fashion, and in some of these the disease causing genes have already been identified. Possible pathogenic mechanisms by which these genes cause Parkinson's disease are discussed. Further candidate genes and systematic efforts to identify genes influencing susceptibility to the disease in general are also summarised. The identification of such susceptibility genes will eventually enable us to more accurately classify this complex disease.
Full Text
The Full Text of this article is available as a PDF (124.0 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barbeau A., Pourcher E. New data on the genetics of Parkinson's disease. Can J Neurol Sci. 1982 Feb;9(1):53–60. doi: 10.1017/s031716710004364x. [DOI] [PubMed] [Google Scholar]
- Betarbet R., Sherer T. B., MacKenzie G., Garcia-Osuna M., Panov A. V., Greenamyre J. T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci. 2000 Dec;3(12):1301–1306. doi: 10.1038/81834. [DOI] [PubMed] [Google Scholar]
- Bonifati V., Fabrizio E., Vanacore N., De Mari M., Meco G. Familial Parkinson's disease: a clinical genetic analysis. Can J Neurol Sci. 1995 Nov;22(4):272–279. doi: 10.1017/s0317167100039469. [DOI] [PubMed] [Google Scholar]
- Brooks D. J., Playford E. D., Ibanez V., Sawle G. V., Thompson P. D., Findley L. J., Marsden C. D. Isolated tremor and disruption of the nigrostriatal dopaminergic system: an 18F-dopa PET study. Neurology. 1992 Aug;42(8):1554–1560. doi: 10.1212/wnl.42.8.1554. [DOI] [PubMed] [Google Scholar]
- Burkhardt C., Kelly J. P., Lim Y. H., Filley C. M., Parker W. D., Jr Neuroleptic medications inhibit complex I of the electron transport chain. Ann Neurol. 1993 May;33(5):512–517. doi: 10.1002/ana.410330516. [DOI] [PubMed] [Google Scholar]
- Burn D. J., Mark M. H., Playford E. D., Maraganore D. M., Zimmerman T. R., Jr, Duvoisin R. C., Harding A. E., Marsden C. D., Brooks D. J. Parkinson's disease in twins studied with 18F-dopa and positron emission tomography. Neurology. 1992 Oct;42(10):1894–1900. doi: 10.1212/wnl.42.10.1894. [DOI] [PubMed] [Google Scholar]
- Carero-Valenzuela R., Lindblad K., Payami H., Johnson W., Schalling M., Stenroos E. S., Shattuc S., Nutt J., Brice A., Litt M. No evidence for association of familial Parkinson's disease with CAG repeat expansion. Neurology. 1995 Sep;45(9):1760–1763. doi: 10.1212/wnl.45.9.1760. [DOI] [PubMed] [Google Scholar]
- Chan D. K., Mellick G., Cai H., Wang X. L., Ng P. W., Pang C. P., Woo J., Kay R. The alpha-synuclein gene and Parkinson disease in a Chinese population. Arch Neurol. 2000 Apr;57(4):501–503. doi: 10.1001/archneur.57.4.501. [DOI] [PubMed] [Google Scholar]
- Checkoway H., Franklin G. M., Costa-Mallen P., Smith-Weller T., Dilley J., Swanson P. D., Costa L. G. A genetic polymorphism of MAO-B modifies the association of cigarette smoking and Parkinson's disease. Neurology. 1998 May;50(5):1458–1461. doi: 10.1212/wnl.50.5.1458. [DOI] [PubMed] [Google Scholar]
- Conway K. A., Lee S. J., Rochet J. C., Ding T. T., Williamson R. E., Lansbury P. T., Jr Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. Proc Natl Acad Sci U S A. 2000 Jan 18;97(2):571–576. doi: 10.1073/pnas.97.2.571. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Conway K. A., Rochet J. C., Bieganski R. M., Lansbury P. T., Jr Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science. 2001 Nov 9;294(5545):1346–1349. doi: 10.1126/science.1063522. [DOI] [PubMed] [Google Scholar]
- De Michele G., Filla A., Volpe G., De Marco V., Gogliettino A., Ambrosio G., Marconi R., Castellano A. E., Campanella G. Environmental and genetic risk factors in Parkinson's disease: a case-control study in southern Italy. Mov Disord. 1996 Jan;11(1):17–23. doi: 10.1002/mds.870110105. [DOI] [PubMed] [Google Scholar]
- De Palma G., Mozzoni P., Mutti A., Calzetti S., Negrotti A. Case-control study of interactions between genetic and environmental factors in Parkinson's disease. Lancet. 1998 Dec 19;352(9145):1986–1987. doi: 10.1016/s0140-6736(05)61332-3. [DOI] [PubMed] [Google Scholar]
- DeMartino G. N., Slaughter C. A. The proteasome, a novel protease regulated by multiple mechanisms. J Biol Chem. 1999 Aug 6;274(32):22123–22126. doi: 10.1074/jbc.274.32.22123. [DOI] [PubMed] [Google Scholar]
- DeStefano A. L., Golbe L. I., Mark M. H., Lazzarini A. M., Maher N. E., Saint-Hilaire M., Feldman R. G., Guttman M., Watts R. L., Suchowersky O. Genome-wide scan for Parkinson's disease: the GenePD Study. Neurology. 2001 Sep 25;57(6):1124–1126. doi: 10.1212/wnl.57.6.1124. [DOI] [PubMed] [Google Scholar]
- Duvoisin R. C., Eldridge R., Williams A., Nutt J., Calne D. Twin study of Parkinson disease. Neurology. 1981 Jan;31(1):77–80. doi: 10.1212/wnl.31.1.77. [DOI] [PubMed] [Google Scholar]
- Elbaz A., Grigoletto F., Baldereschi M., Breteler M. M., Manubens-Bertran J. M., Lopez-Pousa S., Dartigues J. F., Alpérovitch A., Tzourio C., Rocca W. A. Familial aggregation of Parkinson's disease: a population-based case-control study in Europe. EUROPARKINSON Study Group. Neurology. 1999 Jun 10;52(9):1876–1882. doi: 10.1212/wnl.52.9.1876. [DOI] [PubMed] [Google Scholar]
- Farrer M., Destée T., Becquet E., Wavrant-De Vrièze F., Mouroux V., Richard F., Defebvre L., Lincoln S., Hardy J., Amouyel P. Linkage exclusion in French families with probable Parkinson' s disease. Mov Disord. 2000 Nov;15(6):1075–1083. doi: 10.1002/1531-8257(200011)15:6<1075::aid-mds1004>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
- Farrer M., Gwinn-Hardy K., Muenter M., DeVrieze F. W., Crook R., Perez-Tur J., Lincoln S., Maraganore D., Adler C., Newman S. A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor. Hum Mol Genet. 1999 Jan;8(1):81–85. doi: 10.1093/hmg/8.1.81. [DOI] [PubMed] [Google Scholar]
- Farrer M., Maraganore D. M., Lockhart P., Singleton A., Lesnick T. G., de Andrade M., West A., de Silva R., Hardy J., Hernandez D. alpha-Synuclein gene haplotypes are associated with Parkinson's disease. Hum Mol Genet. 2001 Aug 15;10(17):1847–1851. doi: 10.1093/hmg/10.17.1847. [DOI] [PubMed] [Google Scholar]
- Forno L. S. Concentric hyalin intraneuronal inclusions of Lewy type in the brains of elderly persons (50 incidental cases): relationship to parkinsonism. J Am Geriatr Soc. 1969 Jun;17(6):557–575. doi: 10.1111/j.1532-5415.1969.tb01316.x. [DOI] [PubMed] [Google Scholar]
- Funayama Manabu, Hasegawa Kazuko, Kowa Hisayuki, Saito Masaaki, Tsuji Shoji, Obata Fumiya. A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1. Ann Neurol. 2002 Mar;51(3):296–301. doi: 10.1002/ana.10113. [DOI] [PubMed] [Google Scholar]
- Gasser T., Müller-Myhsok B., Wszolek Z. K., Oehlmann R., Calne D. B., Bonifati V., Bereznai B., Fabrizio E., Vieregge P., Horstmann R. D. A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat Genet. 1998 Mar;18(3):262–265. doi: 10.1038/ng0398-262. [DOI] [PubMed] [Google Scholar]
- Gilham D. E., Cairns W., Paine M. J., Modi S., Poulsom R., Roberts G. C., Wolf C. R. Metabolism of MPTP by cytochrome P4502D6 and the demonstration of 2D6 mRNA in human foetal and adult brain by in situ hybridization. Xenobiotica. 1997 Jan;27(1):111–125. doi: 10.1080/004982597240802. [DOI] [PubMed] [Google Scholar]
- Goedert M. Alpha-synuclein and neurodegenerative diseases. Nat Rev Neurosci. 2001 Jul;2(7):492–501. doi: 10.1038/35081564. [DOI] [PubMed] [Google Scholar]
- Goetz C. G., Burke P. F., Leurgans S., Berry-Kravis E., Blasucci L. M., Raman R., Zhou L. Genetic variation analysis in parkinson disease patients with and without hallucinations: case-control study. Arch Neurol. 2001 Feb;58(2):209–213. doi: 10.1001/archneur.58.2.209. [DOI] [PubMed] [Google Scholar]
- Golbe L. I., Di Iorio G., Sanges G., Lazzarini A. M., La Sala S., Bonavita V., Duvoisin R. C. Clinical genetic analysis of Parkinson's disease in the Contursi kindred. Ann Neurol. 1996 Nov;40(5):767–775. doi: 10.1002/ana.410400513. [DOI] [PubMed] [Google Scholar]
- Gwinn-Hardy K. A., Crook R., Lincoln S., Adler C. H., Caviness J. N., Hardy J., Farrer M. A kindred with Parkinson's disease not showing genetic linkage to established loci. Neurology. 2000 Jan 25;54(2):504–507. doi: 10.1212/wnl.54.2.504. [DOI] [PubMed] [Google Scholar]
- Haass C., Kahle P. J. Neuroscience. Parkin and its substrates. Science. 2001 Jul 13;293(5528):224–225. doi: 10.1126/science.1063286. [DOI] [PubMed] [Google Scholar]
- Hardy J., Gwinn-Hardy K. Genetic classification of primary neurodegenerative disease. Science. 1998 Nov 6;282(5391):1075–1079. doi: 10.1126/science.282.5391.1075. [DOI] [PubMed] [Google Scholar]
- Harhangi B. S., Farrer M. J., Lincoln S., Bonifati V., Meco G., De Michele G., Brice A., Dürr A., Martinez M., Gasser T. The Ile93Met mutation in the ubiquitin carboxy-terminal-hydrolase-L1 gene is not observed in European cases with familial Parkinson's disease. Neurosci Lett. 1999 Jul 23;270(1):1–4. doi: 10.1016/s0304-3940(99)00465-6. [DOI] [PubMed] [Google Scholar]
- Hilker R., Klein C., Ghaemi M., Kis B., Strotmann T., Ozelius L. J., Lenz O., Vieregge P., Herholz K., Heiss W. D. Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene. Ann Neurol. 2001 Mar;49(3):367–376. [PubMed] [Google Scholar]
- Hubble J. P., Kurth J. H., Glatt S. L., Kurth M. C., Schellenberg G. D., Hassanein R. E., Lieberman A., Koller W. C. Gene-toxin interaction as a putative risk factor for Parkinson's disease with dementia. Neuroepidemiology. 1998;17(2):96–104. doi: 10.1159/000026159. [DOI] [PubMed] [Google Scholar]
- Hughes A. J., Ben-Shlomo Y., Daniel S. E., Lees A. J. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology. 1992 Jun;42(6):1142–1146. doi: 10.1212/wnl.42.6.1142. [DOI] [PubMed] [Google Scholar]
- Hughes A. J., Daniel S. E., Kilford L., Lees A. J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181–184. doi: 10.1136/jnnp.55.3.181. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Johnson W. G., Hodge S. E., Duvoisin R. Twin studies and the genetics of Parkinson's disease--a reappraisal. Mov Disord. 1990;5(3):187–194. doi: 10.1002/mds.870050302. [DOI] [PubMed] [Google Scholar]
- Khan N., Graham E., Dixon P., Morris C., Mander A., Clayton D., Vaughan J., Quinn N., Lees A., Daniel S. Parkinson's disease is not associated with the combined alpha-synuclein/apolipoprotein E susceptibility genotype. Ann Neurol. 2001 May;49(5):665–668. [PubMed] [Google Scholar]
- Krüger R., Kuhn W., Müller T., Woitalla D., Graeber M., Kösel S., Przuntek H., Epplen J. T., Schöls L., Riess O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet. 1998 Feb;18(2):106–108. doi: 10.1038/ng0298-106. [DOI] [PubMed] [Google Scholar]
- Lachin J. M. Introduction to sample size determination and power analysis for clinical trials. Control Clin Trials. 1981 Jun;2(2):93–113. doi: 10.1016/0197-2456(81)90001-5. [DOI] [PubMed] [Google Scholar]
- Langston J. W., Tanner C. M. Selegiline and Parkinson's disease: it's déjà vu-again. Neurology. 2000 Dec 26;55(12):1770–1771. doi: 10.1212/wnl.55.12.1770. [DOI] [PubMed] [Google Scholar]
- Larsen C. N., Krantz B. A., Wilkinson K. D. Substrate specificity of deubiquitinating enzymes: ubiquitin C-terminal hydrolases. Biochemistry. 1998 Mar 10;37(10):3358–3368. doi: 10.1021/bi972274d. [DOI] [PubMed] [Google Scholar]
- Lazzarini A. M., Myers R. H., Zimmerman T. R., Jr, Mark M. H., Golbe L. I., Sage J. I., Johnson W. G., Duvoisin R. C. A clinical genetic study of Parkinson's disease: evidence for dominant transmission. Neurology. 1994 Mar;44(3 Pt 1):499–506. doi: 10.1212/wnl.44.3_part_1.499. [DOI] [PubMed] [Google Scholar]
- Leroy E., Boyer R., Auburger G., Leube B., Ulm G., Mezey E., Harta G., Brownstein M. J., Jonnalagada S., Chernova T. The ubiquitin pathway in Parkinson's disease. Nature. 1998 Oct 1;395(6701):451–452. doi: 10.1038/26652. [DOI] [PubMed] [Google Scholar]
- Levecque C., Destée A., Mouroux V., Becquet E., Defebvre L., Amouyel P., Chartier-Harlin M. C. No genetic association of the ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism with familial Parkinson's disease. J Neural Transm (Vienna) 2001;108(8-9):979–984. doi: 10.1007/s007020170017. [DOI] [PubMed] [Google Scholar]
- Lincoln S., Vaughan J., Wood N., Baker M., Adamson J., Gwinn-Hardy K., Lynch T., Hardy J., Farrer M. Low frequency of pathogenic mutations in the ubiquitin carboxy-terminal hydrolase gene in familial Parkinson's disease. Neuroreport. 1999 Feb 5;10(2):427–429. doi: 10.1097/00001756-199902050-00040. [DOI] [PubMed] [Google Scholar]
- Lowe J., McDermott H., Landon M., Mayer R. J., Wilkinson K. D. Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases. J Pathol. 1990 Jun;161(2):153–160. doi: 10.1002/path.1711610210. [DOI] [PubMed] [Google Scholar]
- Lücking C. B., Dürr A., Bonifati V., Vaughan J., De Michele G., Gasser T., Harhangi B. S., Meco G., Denèfle P., Wood N. W. Association between early-onset Parkinson's disease and mutations in the parkin gene. N Engl J Med. 2000 May 25;342(21):1560–1567. doi: 10.1056/NEJM200005253422103. [DOI] [PubMed] [Google Scholar]
- Makoff A. J., Graham J. M., Arranz M. J., Forsyth J., Li T., Aitchison K. J., Shaikh S., Grünewald R. A. Association study of dopamine receptor gene polymorphisms with drug-induced hallucinations in patients with idiopathic Parkinson's disease. Pharmacogenetics. 2000 Feb;10(1):43–48. doi: 10.1097/00008571-200002000-00006. [DOI] [PubMed] [Google Scholar]
- Maraganore D. M., Harding A. E., Marsden C. D. A clinical and genetic study of familial Parkinson's disease. Mov Disord. 1991;6(3):205–211. doi: 10.1002/mds.870060303. [DOI] [PubMed] [Google Scholar]
- Marder K., Tang M. X., Mejia H., Alfaro B., Côté L., Louis E., Groves J., Mayeux R. Risk of Parkinson's disease among first-degree relatives: A community-based study. Neurology. 1996 Jul;47(1):155–160. doi: 10.1212/wnl.47.1.155. [DOI] [PubMed] [Google Scholar]
- Mark M. H., Dickson D. W., Sage J. I., Duvoisin R. C. The clinicopathologic spectrum of Lewy body disease. Adv Neurol. 1996;69:315–318. [PubMed] [Google Scholar]
- Markopoulou K., Wszolek Z. K., Pfeiffer R. F. A Greek-American kindred with autosomal dominant, levodopa-responsive parkinsonism and anticipation. Ann Neurol. 1995 Sep;38(3):373–378. doi: 10.1002/ana.410380306. [DOI] [PubMed] [Google Scholar]
- Marsden C. D. Parkinson's disease in twins. J Neurol Neurosurg Psychiatry. 1987 Jan;50(1):105–106. doi: 10.1136/jnnp.50.1.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Martin E. R., Scott W. K., Nance M. A., Watts R. L., Hubble J. P., Koller W. C., Lyons K., Pahwa R., Stern M. B., Colcher A. Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease. JAMA. 2001 Nov 14;286(18):2245–2250. doi: 10.1001/jama.286.18.2245. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Martin W. E., Young W. I., Anderson V. E. Parkinson's disease. A genetic study. Brain. 1973 Sep;96(3):495–506. doi: 10.1093/brain/96.3.495. [DOI] [PubMed] [Google Scholar]
- Marttila R. J., Kaprio J., Koskenvuo M., Rinne U. K. Parkinson's disease in a nationwide twin cohort. Neurology. 1988 Aug;38(8):1217–1219. doi: 10.1212/wnl.38.8.1217. [DOI] [PubMed] [Google Scholar]
- Matsumine H., Saito M., Shimoda-Matsubayashi S., Tanaka H., Ishikawa A., Nakagawa-Hattori Y., Yokochi M., Kobayashi T., Igarashi S., Takano H. Localization of a gene for an autosomal recessive form of juvenile Parkinsonism to chromosome 6q25.2-27. Am J Hum Genet. 1997 Mar;60(3):588–596. [PMC free article] [PubMed] [Google Scholar]
- McNaught K. S., Olanow C. W., Halliwell B., Isacson O., Jenner P. Failure of the ubiquitin-proteasome system in Parkinson's disease. Nat Rev Neurosci. 2001 Aug;2(8):589–594. doi: 10.1038/35086067. [DOI] [PubMed] [Google Scholar]
- Menegon A., Board P. G., Blackburn A. C., Mellick G. D., Le Couteur D. G. Parkinson's disease, pesticides, and glutathione transferase polymorphisms. Lancet. 1998 Oct 24;352(9137):1344–1346. doi: 10.1016/s0140-6736(98)03453-9. [DOI] [PubMed] [Google Scholar]
- Mizuno Y., Yoshino H., Ikebe S., Hattori N., Kobayashi T., Shimoda-Matsubayashi S., Matsumine H., Kondo T. Mitochondrial dysfunction in Parkinson's disease. Ann Neurol. 1998 Sep;44(3 Suppl 1):S99–109. doi: 10.1002/ana.410440715. [DOI] [PubMed] [Google Scholar]
- Morens D. M., Grandinetti A., Reed D., White L. R., Ross G. W. Cigarette smoking and protection from Parkinson's disease: false association or etiologic clue? Neurology. 1995 Jun;45(6):1041–1051. doi: 10.1212/wnl.45.6.1041. [DOI] [PubMed] [Google Scholar]
- Nagar S., Juyal R. C., Chaudhary S., Behari M., Gupta M., Rao S. N., Thelma B. K. Mutations in the alpha-synuclein gene in Parkinson's disease among Indians. Acta Neurol Scand. 2001 Feb;103(2):120–122. doi: 10.1034/j.1600-0404.2001.103002120.x. [DOI] [PubMed] [Google Scholar]
- Nicholl D. J., Vaughan J. R., Khan N. L., Ho S. L., Aldous D. E. W., Lincoln S., Farrer M., Gayton J. D., Davis M. B., Piccini P. Two large British kindreds with familial Parkinson's disease: a clinico-pathological and genetic study. Brain. 2002 Jan;125(Pt 1):44–57. doi: 10.1093/brain/awf013. [DOI] [PubMed] [Google Scholar]
- Parker W. D., Jr, Swerdlow R. H. Mitochondrial dysfunction in idiopathic Parkinson disease. Am J Hum Genet. 1998 Apr;62(4):758–762. doi: 10.1086/301812. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Payami H., Bernard S., Larsen K., Kaye J., Nutt J. Genetic anticipation in Parkinson's disease. Neurology. 1995 Jan;45(1):135–138. doi: 10.1212/wnl.45.1.135. [DOI] [PubMed] [Google Scholar]
- Payami H., Larsen K., Bernard S., Nutt J. Increased risk of Parkinson's disease in parents and siblings of patients. Ann Neurol. 1994 Oct;36(4):659–661. doi: 10.1002/ana.410360417. [DOI] [PubMed] [Google Scholar]
- Piccini P., Burn D. J., Ceravolo R., Maraganore D., Brooks D. J. The role of inheritance in sporadic Parkinson's disease: evidence from a longitudinal study of dopaminergic function in twins. Ann Neurol. 1999 May;45(5):577–582. doi: 10.1002/1531-8249(199905)45:5<577::aid-ana5>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
- Planté-Bordeneuve V., Taussig D., Thomas F., Ziégler M., Said G. A clinical and genetic study of familial cases of Parkinson's disease. J Neurol Sci. 1995 Nov;133(1-2):164–172. doi: 10.1016/0022-510x(95)00190-d. [DOI] [PubMed] [Google Scholar]
- Polymeropoulos M. H., Higgins J. J., Golbe L. I., Johnson W. G., Ide S. E., Di Iorio G., Sanges G., Stenroos E. S., Pho L. T., Schaffer A. A. Mapping of a gene for Parkinson's disease to chromosome 4q21-q23. Science. 1996 Nov 15;274(5290):1197–1199. doi: 10.1126/science.274.5290.1197. [DOI] [PubMed] [Google Scholar]
- Polymeropoulos M. H., Lavedan C., Leroy E., Ide S. E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 1997 Jun 27;276(5321):2045–2047. doi: 10.1126/science.276.5321.2045. [DOI] [PubMed] [Google Scholar]
- Pulst S. M. Genetic linkage analysis. Arch Neurol. 1999 Jun;56(6):667–672. doi: 10.1001/archneur.56.6.667. [DOI] [PubMed] [Google Scholar]
- Rostami-Hodjegan A., Lennard M. S., Woods H. F., Tucker G. T. Meta-analysis of studies of the CYP2D6 polymorphism in relation to lung cancer and Parkinson's disease. Pharmacogenetics. 1998 Jun;8(3):227–238. doi: 10.1097/00008571-199806000-00005. [DOI] [PubMed] [Google Scholar]
- Schapira A. H., Cooper J. M., Dexter D., Jenner P., Clark J. B., Marsden C. D. Mitochondrial complex I deficiency in Parkinson's disease. Lancet. 1989 Jun 3;1(8649):1269–1269. doi: 10.1016/s0140-6736(89)92366-0. [DOI] [PubMed] [Google Scholar]
- Scott W. K., Nance M. A., Watts R. L., Hubble J. P., Koller W. C., Lyons K., Pahwa R., Stern M. B., Colcher A., Hiner B. C. Complete genomic screen in Parkinson disease: evidence for multiple genes. JAMA. 2001 Nov 14;286(18):2239–2244. doi: 10.1001/jama.286.18.2239. [DOI] [PubMed] [Google Scholar]
- Scott W. K., Yamaoka L. H., Stajich J. M., Scott B. L., Vance J. M., Roses A. D., Pericak-Vance M. A., Watts R. L., Nance M., Hubble J. The alpha-synuclein gene is not a major risk factor in familial Parkinson disease. Neurogenetics. 1999 Sep;2(3):191–192. doi: 10.1007/s100480050083. [DOI] [PubMed] [Google Scholar]
- Semchuk K. M., Love E. J., Lee R. G. Parkinson's disease: a test of the multifactorial etiologic hypothesis. Neurology. 1993 Jun;43(6):1173–1180. doi: 10.1212/wnl.43.6.1173. [DOI] [PubMed] [Google Scholar]
- Shimura H., Hattori N., Kubo S. i., Mizuno Y., Asakawa S., Minoshima S., Shimizu N., Iwai K., Chiba T., Tanaka K. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet. 2000 Jul;25(3):302–305. doi: 10.1038/77060. [DOI] [PubMed] [Google Scholar]
- Shimura H., Schlossmacher M. G., Hattori N., Frosch M. P., Trockenbacher A., Schneider R., Mizuno Y., Kosik K. S., Selkoe D. J. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Science. 2001 Jun 28;293(5528):263–269. doi: 10.1126/science.1060627. [DOI] [PubMed] [Google Scholar]
- Spillantini M. G., Goedert M. Tau and Parkinson disease. JAMA. 2001 Nov 14;286(18):2324–2326. doi: 10.1001/jama.286.18.2324. [DOI] [PubMed] [Google Scholar]
- Spillantini M. G., Schmidt M. L., Lee V. M., Trojanowski J. Q., Jakes R., Goedert M. Alpha-synuclein in Lewy bodies. Nature. 1997 Aug 28;388(6645):839–840. doi: 10.1038/42166. [DOI] [PubMed] [Google Scholar]
- Sveinbjörnsdottir S., Hicks A. A., Jonsson T., Pétursson H., Guğmundsson G., Frigge M. L., Kong A., Gulcher J. R., Stefansson K. Familial aggregation of Parkinson's disease in Iceland. N Engl J Med. 2000 Dec 14;343(24):1765–1770. doi: 10.1056/NEJM200012143432404. [DOI] [PubMed] [Google Scholar]
- Swerdlow R. H., Parks J. K., Davis J. N., 2nd, Cassarino D. S., Trimmer P. A., Currie L. J., Dougherty J., Bridges W. S., Bennett J. P., Jr, Wooten G. F. Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family. Ann Neurol. 1998 Dec;44(6):873–881. doi: 10.1002/ana.410440605. [DOI] [PubMed] [Google Scholar]
- Tan E. K., Khajavi M., Thornby J. I., Nagamitsu S., Jankovic J., Ashizawa T. Variability and validity of polymorphism association studies in Parkinson's disease. Neurology. 2000 Aug 22;55(4):533–538. doi: 10.1212/wnl.55.4.533. [DOI] [PubMed] [Google Scholar]
- Tan E. K., Matsuura T., Nagamitsu S., Khajavi M., Jankovic J., Ashizawa T. Polymorphism of NACP-Rep1 in Parkinson's disease: an etiologic link with essential tremor? Neurology. 2000 Mar 14;54(5):1195–1198. doi: 10.1212/wnl.54.5.1195. [DOI] [PubMed] [Google Scholar]
- Tanner C. M., Ottman R., Goldman S. M., Ellenberg J., Chan P., Mayeux R., Langston J. W. Parkinson disease in twins: an etiologic study. JAMA. 1999 Jan 27;281(4):341–346. doi: 10.1001/jama.281.4.341. [DOI] [PubMed] [Google Scholar]
- Taylor C. A., Saint-Hilaire M. H., Cupples L. A., Thomas C. A., Burchard A. E., Feldman R. G., Myers R. H. Environmental, medical, and family history risk factors for Parkinson's disease: a New England-based case control study. Am J Med Genet. 1999 Dec 15;88(6):742–749. [PubMed] [Google Scholar]
- Uitti R. J., Shinotoh H., Hayward M., Schulzer M., Mak E., Calne D. B. "Familial Parkinson's disease"--a case-control study of families. Can J Neurol Sci. 1997 May;24(2):127–132. doi: 10.1017/s0317167100021454. [DOI] [PubMed] [Google Scholar]
- Valente E. M., Bentivoglio A. R., Dixon P. H., Ferraris A., Ialongo T., Frontali M., Albanese A., Wood N. W. Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36. Am J Hum Genet. 2001 Mar 7;68(4):895–900. doi: 10.1086/319522. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Valente Enza Maria, Brancati Francesco, Ferraris Alessandro, Graham Elizabeth A., Davis Mary B., Breteler Monique M. B., Gasser Thomas, Bonifati Vincenzo, Bentivoglio Anna Rita, De Michele Giuseppe. PARK6-linked parkinsonism occurs in several European families. Ann Neurol. 2002 Jan;51(1):14–18. [PubMed] [Google Scholar]
- Vieregge P., Heberlein I. Increased risk of Parkinson's disease in relatives of patients. Ann Neurol. 1995 May;37(5):685–685. doi: 10.1002/ana.410370525. [DOI] [PubMed] [Google Scholar]
- Volles M. J., Lee S. J., Rochet J. C., Shtilerman M. D., Ding T. T., Kessler J. C., Lansbury P. T., Jr Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease. Biochemistry. 2001 Jul 3;40(26):7812–7819. doi: 10.1021/bi0102398. [DOI] [PubMed] [Google Scholar]
- Ward C. D., Duvoisin R. C., Ince S. E., Nutt J. D., Eldridge R., Calne D. B. Parkinson's disease in 65 pairs of twins and in a set of quadruplets. Neurology. 1983 Jul;33(7):815–824. doi: 10.1212/wnl.33.7.815. [DOI] [PubMed] [Google Scholar]
- Ward C. D., Gibb W. R. Research diagnostic criteria for Parkinson's disease. Adv Neurol. 1990;53:245–249. [PubMed] [Google Scholar]
- Young W. I., Martin W. E., Anderson V. E. The distribution of ancestral secondary cases in Parkinson's disease. Clin Genet. 1977 Mar;11(3):189–192. doi: 10.1111/j.1399-0004.1977.tb01298.x. [DOI] [PubMed] [Google Scholar]
- Zareparsi S., Taylor T. D., Harris E. L., Payami H. Segregation analysis of Parkinson disease. Am J Med Genet. 1998 Dec 4;80(4):410–417. doi: 10.1002/(sici)1096-8628(19981204)80:4<410::aid-ajmg21>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
- van Duijn C. M., Dekker M. C., Bonifati V., Galjaard R. J., Houwing-Duistermaat J. J., Snijders P. J., Testers L., Breedveld G. J., Horstink M., Sandkuijl L. A. Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36. Am J Hum Genet. 2001 Jul 2;69(3):629–634. doi: 10.1086/322996. [DOI] [PMC free article] [PubMed] [Google Scholar]